--- title: "Cerebrolysin Peptide SA - Compare Prices from 2 Suppliers - PeptideSupermarket®" description: "Compare Cerebrolysin prices from 2 SA suppliers, from R500.00. Find the cheapest deals, read reviews and save money." url: "https://peptidesupermarket.co.za/peptide/cerebrolysin" site: "PeptideSupermarket®" country: "South Africa" --- [Home](https://peptidesupermarket.co.za) › [Peptides](https://peptidesupermarket.co.za/compare-peptide-prices-za) › Cerebrolysin Search # Cerebrolysin Price Comparison Live prices from 2 SA suppliers, from R500.00, compared side by side so you never overpay. [Neuropeptides & sleep research](https://peptidesupermarket.co.za/compare-peptide-prices-za) Prices checked 1 hour ago We compare prices & may earn a commission. [Full disclosure](https://peptidesupermarket.co.za/disclosure). Best Price R500.00 Average R574.50 Highest R649.00 You Could Save 23% 2 results 60mg Compare 2 prices for Cerebrolysin. Cheapest: R500.00. Average: R574.50. | Compare | Supplier | Price | Price / mg | Stock | Delivery | Quality | Coupon | Visit | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | [Crono Pharm](https://peptidesupermarket.co.za/suppliers/chrono-pharm) Best Cerebrolysin 60mg | R500.00 | R8.33/mg | Out of Stock | R150.00 | Lab Tested | — | Visit | | | [Reschem](https://peptidesupermarket.co.za/suppliers/reschem) Cerebrolysin Pen | R649.00 | R10.82/mg | Out of Stock | Free over R600 | Lab Tested | — | Visit | More ways to compare Cerebrolysin Different views of the same live SA pricing, tuned for how you like to shop. [Best Cerebrolysin Prices Best prices ranked](https://peptidesupermarket.co.za/best-cerebrolysin-prices) [Cheapest Cerebrolysin Prices Cheapest suppliers compared](https://peptidesupermarket.co.za/cheapest-cerebrolysin-prices) [Where to Buy Cerebrolysin Full buyer's guide](https://peptidesupermarket.co.za/where-to-buy-cerebrolysin) [Buy Cerebrolysin Online SA Cheap Today's hottest deals](https://peptidesupermarket.co.za/buy-cerebrolysin-online-za-cheap) [Cerebrolysin Price Comparison Live price dashboard](https://peptidesupermarket.co.za/cerebrolysin-price-comparison) [Cerebrolysin SA Supplier Verified SA supplier directory](https://peptidesupermarket.co.za/cerebrolysin-za-supplier) [Cerebrolysin For Sale Browse listings for sale](https://peptidesupermarket.co.za/cerebrolysin-for-sale) Compare another peptide Search PeptideSupermarket® compares prices but doesn't sell products. More All purchases are made directly from third-party suppliers; your relationship is solely with them. We accept no liability for the quality, purity, or legality of any products listed. We may earn a commission when you click through to a supplier and make a purchase. This does not affect pricing information displayed. By using this site you accept responsibility for ensuring purchases comply with applicable laws in your jurisdiction. [Read our full disclosure](https://peptidesupermarket.co.za/disclosure). ## Cerebrolysin Profile Well Studied Neuropeptide Preparation | Neurological Recovery ### Overview Standardized neuropeptide preparation containing bioactive peptides and amino acids exhibiting neurotrophic and neuroprotective properties for stroke recovery, traumatic brain injury, and cognitive enhancement. Used clinically in 50+ countries. ### Mechanism of Action IV/IM administration provides optimal bioavailability and brain penetration of neuropeptides and neurotrophic factors. ### Key Benefits - Direct brain delivery - Standardized dosing - Extensive clinical evidence - Ready-to-use formulation - Used clinically in 50+ countries ### Quick Stats Typical Dose 10-50mL depending on indication (stroke/TBI higher doses) Frequency Once daily for acute conditions; 5 days weekly for chronic conditions Cycle Duration 7-30 days depending on condition (stroke/TBI 10-30 days, dementia 4 weeks) Storage Room temperature ≤25°C, protected from light in original carton - never freeze ## Molecular Information Molecular Weight Variable Length Multiple peptides Type Purified porcine brain proteins Half-Life Minutes (component-dependent; e.g., BDNF ~10 min) ### Amino Acid Sequence `Bioactive peptide mixture` ### Modifications Standardized neuropeptide preparation ## Research Indications The following information is derived from published scientific literature and is provided for educational and research reference purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. These peptides are not approved for human use and are sold exclusively for in-vitro laboratory research. Cognitive Neuroprotection Recovery ## Dosing Protocols ### injectable Primary administration route with well-established protocols for direct brain delivery via IV/IM. | Goal | Dose | Frequency | Route | | --- | --- | --- | --- | | Small Volume IV | Up to 10mL | Once daily | Undiluted IV slow push over 3 minutes | | Intramuscular | Up to 5mL | Once daily | Undiluted IM injection over 3 minutes | | Acute Stroke | 20-50mL | Once daily for 10-21 days | IV infusion (diluted to 100mL minimum) | | Traumatic Brain Injury | 20-50mL | Once daily for 7-30 days | IV infusion (diluted to 100mL minimum) | | Alzheimer's Disease | 10-30mL | 5 days weekly for 4 weeks | IV injection/infusion (2-4 cycles yearly) | | Vascular Dementia | 10-30mL | 5 days weekly for 4 weeks | IV injection/infusion (2-4 cycles yearly) | #### Key Tips - Direct brain delivery - Standardized dosing - Optimal bioavailability - Extensive clinical documentation Reconstitution Instructions ## Peptide Interactions #### Piracetam Compatible Safe combination with no significant interactions; both support cognitive function. #### Donepezil Compatible No interactions reported; may have synergistic cognitive effects in Alzheimer's treatment. #### SSRIs Monitor Potential additive neurotropic effects; monitor for enhanced antidepressant effects. #### Tricyclic Antidepressants Monitor May have additive neurological effects; requires careful monitoring. #### Amino Acid Solutions Avoid Contraindicated per prescribing information; do not mix in same infusion. #### Cardiovascular Medications Avoid Should not be mixed in same IV infusion per official guidelines. #### Vitamin Solutions Avoid Compatibility issues; do not mix in same IV infusion. #### Noopept Monitor Both enhance neurotrophic factors; potential additive effects—start with lower doses. ## What to Expect Week 1-2 Initial neuroprotective effects; possible mild side effects (dizziness, agitation) Week 2-4 Neurological improvements become apparent; cognitive function may begin to improve Week 4-8 Continued recovery; motor function improvements in stroke/TBI patients Week 8-12 Sustained benefits; cognitive enhancement plateaus in chronic conditions ## Side Effects & Safety #### Common Side Effects - Generally well tolerated - Possible mild dizziness or agitation in early treatment #### Monitoring - Monitor for allergic reactions during first dose - Renal function in patients with kidney disease - Seizure activity in at-risk patients - Cardiovascular status during administration #### Stop Signs - Severe allergic reactions (anaphylaxis, severe rash) - New onset seizure activity - Significant cardiovascular events during administration - Severe renal dysfunction or worsening kidney function #### Contraindications - Epilepsy - Severe renal insufficiency - History of severe allergic reactions to porcine products ## Quality Checklist #### Good Signs - Clear amber solution from reputable source - Room temperature storage ≤25°C - Protected from light in original carton - Authorized EVER Pharma distributor #### Warning Signs - Some published studies have been retracted due to research misconduct; rely on independent meta-analyses #### Bad Signs - Frozen product or improper storage—never freeze - Mixing with incompatible solutions (amino acids, vitamins, cardiovascular medications) ## Research & References ### Key References 1. 2020 #### CAPTAIN II Trial - Traumatic Brain Injury Randomized controlled trial demonstrating efficacy and safety in moderate-severe TBI with improved GCS and GOS scores. 2. 2017 #### Nine-Trial Stroke Meta-Analysis - Positive Results Largest positive meta-analysis showing significant neurological improvements in 1,879 stroke patients with NNT=7.7. 3. 2017 #### Conflicting Stroke Meta-Analysis - Neutral Results Independent meta-analysis of 1,779 patients found no significant benefits in functional outcomes (mRS/BI). 4. 2023 #### TBI Systematic Review - Positive Outcomes Analysis of 8,749 TBI patients across 10 studies confirms statistically significant GCS/GOS improvements. [Search PubMed for Cerebrolysin](https://pubmed.ncbi.nlm.nih.gov/?term=%28%22Cerebrolysin%22%20OR%20%22Cerebrolysin%20%28a%20peptide%20mixture%20derived%20from%20porcine%20brain%20tissue%2C%20primarily%20containing%20neuropeptides%20such%20as%20fragment%201%E2%80%934%20of%20beta-amyloid%20and%20other%20neurotrophic%20factors%29%22%20OR%20%22Cerebrolysin%C2%AE%22%29) --- *Add `.md` to any page URL on peptidesupermarket.co.za for its Markdown version. Index of the site: https://peptidesupermarket.co.za/llms.txt - full text: https://peptidesupermarket.co.za/llms-full.txt.*